4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Registry Evaluation of a Double Balloon Accessory Device

Registry Evaluation of a Double Balloon Accessory Device

Study Description
Brief Summary:
This study is collecting standard of care information pertaining to the use of the accessory device and patient outcomes when this double balloon accessory device is used during endoscopic procedures in the colon.

Condition or disease Intervention/treatment
Adenomatous Polyp of Colon Device: Double balloon accessory device

Study Design
Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 165 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 30 Days
Official Title: Multi-center Prospective Registry Study Utilizing a Double Balloon Accessory Device to Facilitate Endoscopic Polypectomy in Large Intestine.
Actual Study Start Date : January 22, 2019
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : March 31, 2021
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
  1. Ability to perform the procedure safely and effectively with the study device. [ Time Frame: Intraoperatively ]
    Investigator answers yes or no


Secondary Outcome Measures :
  1. Time to reach target lesion [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  2. Time to remove lesion after intervention begins [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  3. Total time using study device during case [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  4. Total case time [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  5. Total defect closure time [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes

  6. User feedback on device performance [ Time Frame: Intraoperatively ]
    Investigator rates the ease of use (easy, somewhat easy, somewhat difficult and difficult) of the device.

  7. Number of Study Subjects with Treatment Related Adverse Events [ Time Frame: Up to 30 days ]
    No moderate to severe mucosal injury, perforations or bleeding related to the use of the device.


Eligibility Criteria
Contacts and Locations
Tracking Information
First Submitted Date May 3, 2019
First Posted Date May 8, 2019
Last Update Posted Date December 11, 2020
Actual Study Start Date January 22, 2019
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 7, 2019)
Ability to perform the procedure safely and effectively with the study device. [ Time Frame: Intraoperatively ]
Investigator answers yes or no
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: May 7, 2019)
  • Time to reach target lesion [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes
  • Time to remove lesion after intervention begins [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes
  • Total time using study device during case [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes
  • Total case time [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes
  • Total defect closure time [ Time Frame: Intraoperatively ]
    Time measurement in hours and minutes
  • User feedback on device performance [ Time Frame: Intraoperatively ]
    Investigator rates the ease of use (easy, somewhat easy, somewhat difficult and difficult) of the device.
  • Number of Study Subjects with Treatment Related Adverse Events [ Time Frame: Up to 30 days ]
    No moderate to severe mucosal injury, perforations or bleeding related to the use of the device.
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Registry Evaluation of a Double Balloon Accessory Device
Official Title Multi-center Prospective Registry Study Utilizing a Double Balloon Accessory Device to Facilitate Endoscopic Polypectomy in Large Intestine.
Brief Summary This study is collecting standard of care information pertaining to the use of the accessory device and patient outcomes when this double balloon accessory device is used during endoscopic procedures in the colon.
Detailed Description Not Provided
Study Type Observational [Patient Registry]
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration 30 Days
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Investigator's practice
Condition Adenomatous Polyp of Colon
Intervention Device: Double balloon accessory device
Double balloon accessory device is used during the endoscopic polypectomy procedure
Other Name: DiLumen
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Active, not recruiting
Actual Enrollment
 (submitted: December 10, 2020)
165
Original Estimated Enrollment
 (submitted: May 7, 2019)
200
Estimated Study Completion Date March 31, 2021
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  1. Patients scheduled for endoscopic removal of suspected adenomatous benign polyps(s)
  2. Patients capable of giving informed consent in English
  3. No medical contraindication to endoscopic mucosal resection or endoscopic submucosal disection

Exclusion Criteria:

  1. No patients less than 18 years of age.
  2. Any contraindication to colonoscopy with due to subject's colon anatomy (i.e. stricture)
  3. History of open or laparoscopic colorectal surgery
  4. History of Inflammatory Bowel Disease
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT03942965
Other Study ID Numbers DD_20
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: Yes
IPD Sharing Statement
Plan to Share IPD: No
Responsible Party Lumendi, LLC
Study Sponsor Lumendi, LLC
Collaborators Not Provided
Investigators
Principal Investigator: Peter Draganov, MD University of Florida
PRS Account Lumendi, LLC
Verification Date December 2020